Reference library

What Is C-Peptide Testing? Standards & Purity

How C-peptide standards are tested: HPLC purity, mass spec identity, peptide content by amino acid analysis, and what a certificate of analysis must show.

C-peptide testing is an analytical procedure that measures the 31-amino-acid connecting peptide cleaved from proinsulin during insulin maturation. In a research-materials context, "C-peptide testing" means two distinct things that get confused constantly: assay-side testing (immunoassay or LC-MS/MS quantification of C-peptide in a biological matrix, used in laboratory studies) and material-side testing (the identity, purity, and content characterization of a synthetic C-peptide reference material before it enters an experiment). This page covers the second — what a certificate of analysis on a C-peptide reference standard should contain, what the analytical methods actually resolve, what they miss, and when buying a characterized standard is not worth the money.

What Is Actually Being Measured

Human C-peptide is a 31-residue chain, EAEDLQVGQVELGGGPGAGSLQPLALEGSLQ, with a monoisotopic mass of approximately 3018.4 Da and an average molecular weight near 3020.3 Da. It carries no cysteines, no disulfide bridges, and no aromatic tryptophan — which has direct analytical consequences. With only a handful of weakly absorbing residues and no Trp or Tyr, UV detection at 280 nm is nearly useless. Quantification by chromatography relies on peptide-bond absorbance at 214–220 nm, where the response is far less selective and every solvent impurity in the mobile phase shows up as baseline.

That single structural fact drives most of the analytical difficulty. A supplier reporting "purity by HPLC at 280 nm" for C-peptide either copied a template from a different product or does not understand the molecule. It is one of the fastest tells on a fraudulent or auto-generated certificate.

The Two Numbers That Are Not the Same Number

The most common error in evaluating a C-peptide reference material is treating chromatographic purity and peptide content as interchangeable. They are not, and the gap between them is large.

  • Chromatographic purity (HPLC area percent) describes the fraction of UV-absorbing material eluting as the main peak. A typical research-grade specification is ≥95%; higher-tier reference materials are specified at ≥98%.
  • Peptide content (net peptide, usually by amino acid analysis or nitrogen determination) describes how much of the vial's dry mass is actually peptide rather than counterion, residual water, and salt.

For a lyophilized TFA-salt peptide, net peptide content commonly falls between 65% and 85%. A vial labeled "5 mg, 98% purity" containing 75% net peptide holds roughly 3.75 mg of actual C-peptide. Gravimetric preparation without accounting for this introduces a systematic error of 15–35% into every downstream concentration — a bias that no amount of replication will average out, because it is not random.

A certificate that reports HPLC purity but omits net peptide content is describing the shape of the chromatogram, not the contents of the vial.

C-peptide is also unusually acidic — a calculated isoelectric point near 3.2, with six glutamate/aspartate residues and no basic residues except the N-terminus. This affects counterion behavior and hygroscopicity, and it means the peptide will be poorly retained on standard reversed-phase columns at low pH unless the gradient is adjusted accordingly.

What a Complete Certificate of Analysis Contains

A defensible CoA for a synthetic C-peptide reference standard should carry, at minimum:

  • Identity by mass spectrometry — observed monoisotopic or average mass against theoretical, with the actual spectrum image, not a typed number. Tolerance for ESI-MS on a 3 kDa peptide should be within ±1 Da; high-resolution instruments resolve to within 5 ppm.
  • Purity by RP-HPLC at 214 nm or 220 nm, with the chromatogram attached, gradient program stated, column chemistry (typically C18, 4.6 × 250 mm, 5 µm), run time, and integration parameters visible.
  • Net peptide content, method named (AAA is the defensible one; nitrogen-based estimates are weaker).
  • Counterion identity and level — TFA vs. acetate, with residual TFA typically 5–15% by mass on a TFA-salt preparation.
  • Water content by Karl Fischer, generally 3–8% for a properly lyophilized peptide.
  • Batch/lot number that ties to a retained sample, plus manufacture and retest dates.

The distinction between a retest date and an expiration date matters more than most buyers realize. A retest date means the material is re-analyzed and, if conforming, the date extends. An expiration date is a hard stop with no re-analysis behind it — frequently just 24 months added to the fill date as a formality. Ask which one you are being sold. Our quality documentation covers how lot records tie back to retained samples, and the broader library has comparative write-ups on supplier documentation standards.

Storage, Stability, and the Numbers That Matter

Lyophilized C-peptide stored at −20 °C, desiccated and protected from light, is generally specified as stable for 24–36 months. At −80 °C that extends considerably. At 2–8 °C, expect a working window measured in weeks, not years. At ambient temperature — say 25 °C during a five-day summer transit — the lyophilized powder is more robust than most buyers assume, but the assumption is worth verifying against the lot's own data rather than a generic statement.

In solution, the picture changes sharply. Aqueous C-peptide solutions are the failure point in most stability complaints. Freeze-thaw cycling is the specific culprit: three or more freeze-thaw cycles on an aqueous aliquot is where measurable loss typically begins to appear, driven by adsorption to container surfaces as much as by chemical degradation. Low-bind polypropylene matters here; borosilicate glass and standard polypropylene both show non-trivial adsorptive loss at low concentrations. Below roughly 1 µg/mL, surface adsorption becomes a dominant source of variance rather than a footnote.

Shipping condition is worth checking on the order confirmation, not after arrival. Reference our shipping page for what conditions are used and what documentation accompanies each shipment.

When C-Peptide Testing Is Not Worth It

This is the section that argues against the purchase, and it is the honest part of the page.

Do not buy a certified reference material if your study is qualitative. If you are confirming presence/absence, running a method-development scouting gradient, or establishing retention time for a chromatographic method, a research-grade material at 95% purity does the job. Paying $400–$900 for a fully characterized standard when a $90–$180 research-grade lot resolves the question is money spent on documentation you will not use. The premium buys traceability, not chemistry.

Do not buy synthetic C-peptide if your assay measures endogenous C-peptide in a complex matrix and you have not addressed the matrix effect. A pure synthetic standard in buffer does not replicate ion suppression in serum or plasma. Calibrating an LC-MS/MS method against a neat standard while running samples in a matrix can produce 20–40% quantification bias. The correct answer there is a stable-isotope-labeled internal standard — typically ¹³C/¹⁵N-labeled C-peptide — which costs substantially more, often $1,200–$3,000 for a research-scale quantity. Buying the unlabeled standard because it is cheaper does not solve the problem you actually have; it just makes the failure less visible.

Do not buy a large lot to save on unit cost if your consumption rate is low. A 100 mg lot at a lower per-milligram price is a poor purchase if the project consumes 5 mg per year and the retest date arrives at month 30. Five 10 mg vials purchased against demand, even at a 30–50% unit-price premium, will usually beat one large lot that expires at 60% unused. Volume economics only work when consumption is real — wholesale pricing is worth pursuing when it is, and worth ignoring when it isn't.

Do not assume species cross-reactivity. Human, rat, and mouse C-peptide differ in sequence. Rat C-peptide I and II are distinct from each other and both differ substantially from human. An immunoassay raised against human C-peptide may show under 10% cross-reactivity with rodent C-peptide, or may show none. Ordering human C-peptide for a rodent study because it was the SKU that came up in search is a real and recurring error.

Additional failure modes worth naming plainly:

  • Proinsulin cross-reactivity. Intact proinsulin contains the C-peptide sequence. Many immunoassays cross-react at 5–90% depending on antibody epitope. If your matrix has elevated proinsulin, a C-peptide number is not a clean C-peptide number, and the standard you buy cannot fix an antibody selectivity problem.
  • Deamidation. The sequence contains multiple Gln residues. Deamidation adds +0.98 Da and often co-elutes closely with the parent peak. A 5 µm C18 column running a shallow gradient may not resolve it; the impurity is then silently counted as main peak. Ask whether the purity method was demonstrated to be stability-indicating.
  • Aggregation and adsorption at low concentration. Discussed above, and consistently underestimated.
  • CoAs that do not belong to your lot. A generic PDF with no lot number, or one whose lot number does not match the vial label, is not documentation. Match them before opening the vial.
  • Absent retained samples. If the supplier cannot re-analyze from a retained sample when a result looks wrong, you have no path to root-cause an anomaly.

Cost Structure, Realistically

Research-grade synthetic human C-peptide typically runs $90–$250 for 1–5 mg. Fully characterized reference material with AAA-verified net peptide content, full MS spectra, and lot traceability commonly lands at $400–$900 for comparable quantities. Isotope-labeled internal standards run $1,200–$3,000 and up. Custom synthesis with a specified purity threshold and full analytical package generally requires a 4–8 week lead time and a minimum order in the $1,500–$3,000 range.

The rational allocation is straightforward: spend on characterization where a quantitative claim depends on it, and buy research grade where it does not. A lab running a single calibration curve annually and a lab running weekly quantification have genuinely different correct answers, and the more expensive answer is only correct for one of them.

Qualifying the Supplier

Supplier qualification for reference materials is mostly a documentation exercise, and it is one you can complete in an afternoon:

  • Request a sample CoA before ordering. Refusal to provide one is itself the answer.
  • Verify that the lot number on the CoA matches the vial, and that the chromatogram and mass spec are lot-specific images rather than stock graphics.
  • Ask whether the material was synthesized in-house or resold, and whether the analytical data was generated by the seller or inherited from an upstream manufacturer.
  • Ask about retained samples and the retest policy.
  • Confirm what happens if a lot fails your incoming verification — see returns for how that process works here.

Independent incoming verification is the strongest control available. Running your own HPLC on a new lot costs roughly $40–$120 in column time and reagents. Against a $600 standard and a six-month experiment, that is trivially worth it — and it is the single practice that separates labs that catch a bad lot in week one from labs that discover it in the results.

All materials discussed here are supplied for laboratory research use only and are not for human or veterinary use; see research use only for full terms. Questions about lot-specific documentation can go through contact.


Supplied strictly for in-vitro laboratory research by qualified researchers and institutions. Not a drug, food, cosmetic or dietary supplement. Not for human or veterinary consumption. Not evaluated by the FDA.

Every batch ships with its own certificate.

Purity, identity and lot number, documented for the exact vial you receive.

How we test